CI
CX Institutional’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Buy |
4,314
+416
| +11% | +$32.5K | 0.01% | 470 |
|
|
2025
Q1 | $283K | Sell |
3,898
-70
| -2% | -$5.08K | 0.01% | 496 |
|
|
2024
Q4 | $294K | Buy |
+3,968
| New | +$294K | 0.01% | 450 |
|
|
2024
Q3 | – | Sell |
-3,775
| Closed | -$349K | – | 562 |
|
|
2024
Q2 | $349K | Sell |
3,775
-38
| -1% | -$3.51K | 0.02% | 425 |
|
|
2024
Q1 | $364K | Buy |
3,813
+1,240
| +48% | +$118K | 0.02% | 417 |
|
|
2023
Q4 | $196K | Sell |
2,573
-1,059
| -29% | -$80.7K | 0.01% | 492 |
|
|
2023
Q3 | $252K | Sell |
3,632
-885
| -20% | -$61.3K | 0.01% | 437 |
|
|
2023
Q2 | $426K | Buy |
4,517
+131
| +3% | +$12.4K | 0.02% | 365 |
|
|
2023
Q1 | $361K | Buy |
4,386
+434
| +11% | +$35.7K | 0.02% | 386 |
|
|
2022
Q4 | $295K | Buy |
+3,952
| New | +$295K | 0.02% | 431 |
|
|
2022
Q3 | – | Sell |
-1,212
| Closed | -$115K | – | 683 |
|
|
2022
Q2 | $115K | Buy |
+1,212
| New | +$115K | 0.01% | 532 |
|
|
2021
Q4 | – | Sell |
-1,243
| Closed | -$141K | – | 519 |
|
|
2021
Q3 | $141K | Buy |
1,243
+89
| +8% | +$10.1K | 0.01% | 396 |
|
|
2021
Q2 | $120K | Buy |
1,154
+409
| +55% | +$42.5K | 0.01% | 409 |
|
|
2021
Q1 | $62K | Sell |
745
-57
| -7% | -$4.74K | 0.01% | 451 |
|
|
2020
Q4 | $73K | Buy |
802
+269
| +50% | +$24.5K | 0.01% | 396 |
|
|
2020
Q3 | $43K | Buy |
533
+211
| +66% | +$17K | ﹤0.01% | 409 |
|
|
2020
Q2 | $22K | Buy |
322
+242
| +303% | +$16.5K | ﹤0.01% | 420 |
|
|
2020
Q1 | $15K | Buy |
80
+30
| +60% | +$5.63K | ﹤0.01% | 411 |
|
|
2019
Q4 | $12K | Hold |
50
| – | – | ﹤0.01% | 408 |
|
|
2019
Q3 | $11K | Buy |
50
+4
| +9% | +$880 | ﹤0.01% | 449 |
|
|
2019
Q2 | $8K | Hold |
46
| – | – | ﹤0.01% | 523 |
|
|
2019
Q1 | $9K | Buy |
46
+37
| +411% | +$7.24K | ﹤0.01% | 470 |
|
|
2018
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 491 |
|